Meta’s executives will meet in a Delaware court starting Wednesday over a lawsuit filed by three minority shareholders who ...

People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which may reassure users when the therapies are in short supply.

CVS stock surges nearly 50% in 2025, aided by strong Q1 results, raised guidance and easing Medicare regulation risks.

The first trial of oversight liability claims against a public company may prove riskier for Delaware’s elite business court ...

Signing into law the other criminal justice bill, named the Law and Order Act, Stein praised the effort by lawmakers to ...

The most important philosophy we have of AI is that AI will never make decisions. Period. So AI would help us collect the ...

CVS is set to drop Zepbound as a medicine, but will continue to carry other popular weight loss drugs instead.

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...

Health insurance companies, including CVS Caremark, are altering coverage for GLP-1 weight loss medications like Zepbound, ...

Pharmacy giant unleashes comprehensive defense against AG's lawsuits, claiming state action would hurt patients and increase ...